• 2019 Senior Report Senior Report: Older Americans have more options for home care, but still struggling.

    The United Health Foundation has released results of a sweeping new study benchmarking the health of older adults. The America's Health Rankings® Senior Report was created in partnership with GAPNA to improve the health of America's seniors.

    The data will help advanced practice nurses and other providers deliver quality care.

    Find out about it!

  • 38th Annual GAPNA Conference

    October 3-5, 2019 at the Paris Hotel, Las Vegas, NV.

    Focused education; lasting connections, networking, free access to the GAPNA Online Library.

    Earn up to 22 contact hours (including pre-conference workshops).

    Get more information and register now!

  • AwardCall for Excellence Award Nominations

    The awards are: Emerging Chapter Award, Established Chapter Excellence Award, Special Interest Group Excellence Award, Excellence in Clinical Practice Award, Excellence in Community Service Award, Excellence in Education Award, Excellence in Leadership Award, and Excellence in Research Award.

    The nominations are tallied in July and the winners are announced every year during the Awards Celebration at the GAPNA Annual Conference.

    Now is the time to nominate a colleague or yourself - DEADLINE is June 1, 2019.

    Get started... nominate today!

  • FREE continuing education credit is available for the following session:

    "Contemporary Heart Failure Management"

    (session captured at the GAPNA 2018 Annual Conference)

    For May/June 2019 - Get Your Free CNE Now!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer a series of CNE programs available to GAPNA members. "Alzheimer’s Disease Today and Tomorrow: Optimal Treatment and Collaborative Care," is the first program offered.

    What are the state-of-the-art strategies for managing the symptoms of Alzheimer’s disease? How can the multidisciplinary team work together to ensure timely intervention and optimal outcomes?

    Find out about it!

  • Meet the Candidates for the 2019-2020 BOD!
    The time to vote is right now: May 6 - 31, 2019!

    Please take a moment to read about this year’s candidates and why they feel they should be chosen for the position noted.


Key Treatments for High Blood Pressure and High Blood Lipids Do Not Reduce Elderly Patients' Risk of Limited Mobility

Use of angiotensin-converting enzyme (ACE) inhibitors and statins do not reduce the risk of impaired mobility in older adults, a new study finds.

Impairments in mobility are common in older adults, with 15% of older men and 23% of older women unable to walk two to three blocks.

Chronic inflammation has been identified as a factor leading to a decline in functional status, including mobility. Both ACE inhibitors and statins may decrease systemic inflammation

In addition, ACE inhibitors may have a direct effect on muscle mass.

To see if these medications would indirectly have a positive impact on mobility, the researchers followed 3,055 healthy older adults, who had no mobility problems at baseline, for 6.5 years.

At baseline, the participants were in their 70s and had no difficulty walking a quarter-mile, climbing 10 steps, or performing basic activities of daily living; 15.2% used ACE inhibitors and 12.9% used statins. By year 6, ACE inhibitor use increased to 25.6% and statin use to 28.6%.

At the end of the 6.5-year study, 49.8% of the remaining adults had developed mobility limitation.

In separate multivariable models, neither ACE inhibitor use nor statin use was significantly associated with lower risk of mobility limitation.

For more info, see Gray et al. (2011). iAngiotensin-converting enzyme inhibitor and statin use and incident mobility limitation in community-dwelling older adults: The Health, Aging and Body Composition Study. Journal of the American Geriatrics Society, 59(12), 2226-2232.

Related Topic 1: 

GAPNA Newsletter Issue: